Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 3Withdrawn 1Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Sarcoma 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Dermatologic 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 272Leukemia 194Precursor Cell Lymphoblastic Leukemia-Lymphoma 131Lymphoma 108Congenital Abnormalities 68Myelodysplastic Syndromes 63Leukemia, Myelomonocytic, Acute 60Leukemia, Monocytic, Acute 58Leukemia, Erythroblastic, Acute 56Leukemia, Megakaryoblastic, Acute 54Lymphoma, Non-Hodgkin 51Burkitt Lymphoma 44Lymphoma, Mantle-Cell 42Lymphoma, Large B-Cell, Diffuse 41Lymphoma, Follicular 33Leukemia, Myelomonocytic, Chronic 28Anemia, Refractory, with Excess of Blasts 27Hodgkin Disease 26Recurrence 25Lymphoma, Large-Cell, Immunoblastic 25Leukemia, Lymphocytic, Chronic, B-Cell 25Blast Crisis 24Leukemia, Eosinophilic, Acute 19Leukemia, Myelogenous, Chronic, BCR-ABL Positive 18Myeloproliferative Disorders 17Leukemia, Basophilic, Acute 17Lymphoma, B-Cell, Marginal Zone 16Leukemia, Promyelocytic, Acute 16Leukemia, Myeloid, Chronic-Phase 15Leukemia, Myeloid, Accelerated Phase 14

Interventions

Cyclophosphamide 12Whole-Body Irradiation 10fludarabine phosphate 9Rituximab 9Peripheral Blood Stem Cell Transplantation 9Cyclosporine 9Mycophenolic Acid 7Filgrastim 7Etoposide 6Dexamethasone 6Busulfan 6Methotrexate 5Tacrolimus 4Carboplatin 4Bortezomib 4Vorinostat 3Thiotepa 3Radiotherapy 3Lenalidomide 3Irinotecan 3Cytarabine 3Calcium Dobesilate 3merphos 2liposomal amphotericin B 2laromustine 2ixabepilone 2entinostat 2Transplantation 2Therapeutics 2Prednisone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Intraocular Lymphoma × Cytarabine × Clear all
NCT00074178 2017-04-21

Protocol-B

OHSU Knight Cancer Institute

Phase 2 Completed
22 enrolled
Lymphoid

Lymphoma, Intraocular Lymphoma

NCT00074191 2017-04-21

Protocol-A

OHSU Knight Cancer Institute

Phase 2 Completed
1 enrolled
Lymphoid

Lymphoma, Intraocular Lymphoma

NCT00002502 2013-06-27

Combination Chemotherapy and Bone Marrow Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Classical hematologyDermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Intraocular Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡